source Post navigation SGLT-2 Inhibitor Use Linked to Lower Parkinson Disease Risk in T2D – Endocrinology Advisor Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury – Nature.com